| Configuration: Arriba v2.1.0 (Tamura et al. 2026) | Protocol: All fusions, conventional RNA-seq of haematologic cell lines, consensus truth (Tamura et al. 2026 Supplementary Table 3) Dataset: CCLE haematologic malignancy cell lines, conventional RNA-seq (170 cell lines) | 0.14 F1 (all fusions, conventional RNA-seq of cell lines) fraction · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourceArriba on all fusions, conventional RNA-seq (Tamura et al. 2026) rna-fusion-20261009-protocol-tamura2026-all-conventional Aggregation: Not reported Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 3, 'Conventional RNA-seq of cell lines', row 'Arriba', column 'F1' (PDF page text) |
|---|
| Configuration: Arriba v2.1.0 (Tamura et al. 2026) | Protocol: All fusions, conventional RNA-seq of haematologic cell lines, consensus truth (Tamura et al. 2026 Supplementary Table 3) Dataset: CCLE haematologic malignancy cell lines, conventional RNA-seq (170 cell lines) | 677 False negatives (all fusions, conventional RNA-seq of cell lines) count · lower Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourceArriba on all fusions, conventional RNA-seq (Tamura et al. 2026) rna-fusion-20261009-protocol-tamura2026-all-conventional Aggregation: Not reported Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 3, 'Conventional RNA-seq of cell lines', row 'Arriba', column 'False negative' (PDF page text) |
|---|
| Configuration: Arriba v2.1.0 (Tamura et al. 2026) | Protocol: All fusions, conventional RNA-seq of haematologic cell lines, consensus truth (Tamura et al. 2026 Supplementary Table 3) Dataset: CCLE haematologic malignancy cell lines, conventional RNA-seq (170 cell lines) | 9,567 False positives (all fusions, conventional RNA-seq of cell lines) count · lower Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourceArriba on all fusions, conventional RNA-seq (Tamura et al. 2026) rna-fusion-20261009-protocol-tamura2026-all-conventional Aggregation: Not reported Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 3, 'Conventional RNA-seq of cell lines', row 'Arriba', column 'False positive' (PDF page text) |
|---|
| Configuration: Arriba v2.1.0 (Tamura et al. 2026) | Protocol: All fusions, conventional RNA-seq of haematologic cell lines, consensus truth (Tamura et al. 2026 Supplementary Table 3) Dataset: CCLE haematologic malignancy cell lines, conventional RNA-seq (170 cell lines) | 0.08 Precision (all fusions, conventional RNA-seq of cell lines) fraction · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourceArriba on all fusions, conventional RNA-seq (Tamura et al. 2026) rna-fusion-20261009-protocol-tamura2026-all-conventional Aggregation: Not reported Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 3, 'Conventional RNA-seq of cell lines', row 'Arriba', column 'Positive predictive value' (PDF page text) |
|---|
| Configuration: Arriba v2.1.0 (Tamura et al. 2026) | Protocol: All fusions, conventional RNA-seq of haematologic cell lines, consensus truth (Tamura et al. 2026 Supplementary Table 3) Dataset: CCLE haematologic malignancy cell lines, conventional RNA-seq (170 cell lines) | 0.56 Recall (all fusions, conventional RNA-seq of cell lines) fraction · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourceArriba on all fusions, conventional RNA-seq (Tamura et al. 2026) rna-fusion-20261009-protocol-tamura2026-all-conventional Aggregation: Not reported Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 3, 'Conventional RNA-seq of cell lines', row 'Arriba', column 'True positive rate' (PDF page text) |
|---|
| Configuration: Arriba v2.1.0 (Tamura et al. 2026) | Protocol: All fusions, conventional RNA-seq of haematologic cell lines, consensus truth (Tamura et al. 2026 Supplementary Table 3) Dataset: CCLE haematologic malignancy cell lines, conventional RNA-seq (170 cell lines) | 857 True positives (all fusions, conventional RNA-seq of cell lines) count · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourceArriba on all fusions, conventional RNA-seq (Tamura et al. 2026) rna-fusion-20261009-protocol-tamura2026-all-conventional Aggregation: Not reported Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 3, 'Conventional RNA-seq of cell lines', row 'Arriba', column 'True positive' (PDF page text) |
|---|
| Configuration: Arriba v2.1.0 (Tamura et al. 2026) | Protocol: All fusions, targeted RNA-seq of haematologic cell lines, consensus truth (Tamura et al. 2026 Supplementary Table 3) Dataset: Haematologic cancer cell lines, hybridisation-capture targeted RNA-seq (26 cell lines) | 0.3 F1 (all fusions, targeted RNA-seq of cell lines) fraction · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourceArriba on all fusions, targeted RNA-seq (Tamura et al. 2026) rna-fusion-20261009-protocol-tamura2026-all-targeted Aggregation: Not reported Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 3, 'Targeted RNA-seq of cell lines', row 'Arriba', column 'F1' (PDF page text) |
|---|
| Configuration: Arriba v2.1.0 (Tamura et al. 2026) | Protocol: All fusions, targeted RNA-seq of haematologic cell lines, consensus truth (Tamura et al. 2026 Supplementary Table 3) Dataset: Haematologic cancer cell lines, hybridisation-capture targeted RNA-seq (26 cell lines) | 195 False negatives (all fusions, targeted RNA-seq of cell lines) count · lower Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourceArriba on all fusions, targeted RNA-seq (Tamura et al. 2026) rna-fusion-20261009-protocol-tamura2026-all-targeted Aggregation: Not reported Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 3, 'Targeted RNA-seq of cell lines', row 'Arriba', column 'False negative' (PDF page text) |
|---|
| Configuration: Arriba v2.1.0 (Tamura et al. 2026) | Protocol: All fusions, targeted RNA-seq of haematologic cell lines, consensus truth (Tamura et al. 2026 Supplementary Table 3) Dataset: Haematologic cancer cell lines, hybridisation-capture targeted RNA-seq (26 cell lines) | 64 False positives (all fusions, targeted RNA-seq of cell lines) count · lower Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourceArriba on all fusions, targeted RNA-seq (Tamura et al. 2026) rna-fusion-20261009-protocol-tamura2026-all-targeted Aggregation: Not reported Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 3, 'Targeted RNA-seq of cell lines', row 'Arriba', column 'False positive' (PDF page text) |
|---|
| Configuration: Arriba v2.1.0 (Tamura et al. 2026) | Protocol: All fusions, targeted RNA-seq of haematologic cell lines, consensus truth (Tamura et al. 2026 Supplementary Table 3) Dataset: Haematologic cancer cell lines, hybridisation-capture targeted RNA-seq (26 cell lines) | 0.47 Precision (all fusions, targeted RNA-seq of cell lines) fraction · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourceArriba on all fusions, targeted RNA-seq (Tamura et al. 2026) rna-fusion-20261009-protocol-tamura2026-all-targeted Aggregation: Not reported Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 3, 'Targeted RNA-seq of cell lines', row 'Arriba', column 'Positive predictive value' (PDF page text) |
|---|
| Configuration: Arriba v2.1.0 (Tamura et al. 2026) | Protocol: All fusions, targeted RNA-seq of haematologic cell lines, consensus truth (Tamura et al. 2026 Supplementary Table 3) Dataset: Haematologic cancer cell lines, hybridisation-capture targeted RNA-seq (26 cell lines) | 0.22 Recall (all fusions, targeted RNA-seq of cell lines) fraction · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourceArriba on all fusions, targeted RNA-seq (Tamura et al. 2026) rna-fusion-20261009-protocol-tamura2026-all-targeted Aggregation: Not reported Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 3, 'Targeted RNA-seq of cell lines', row 'Arriba', column 'True positive rate' (PDF page text) |
|---|
| Configuration: Arriba v2.1.0 (Tamura et al. 2026) | Protocol: All fusions, targeted RNA-seq of haematologic cell lines, consensus truth (Tamura et al. 2026 Supplementary Table 3) Dataset: Haematologic cancer cell lines, hybridisation-capture targeted RNA-seq (26 cell lines) | 56 True positives (all fusions, targeted RNA-seq of cell lines) count · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourceArriba on all fusions, targeted RNA-seq (Tamura et al. 2026) rna-fusion-20261009-protocol-tamura2026-all-targeted Aggregation: Not reported Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 3, 'Targeted RNA-seq of cell lines', row 'Arriba', column 'True positive' (PDF page text) |
|---|
| Configuration: Arriba v2.1.0 (Tamura et al. 2026) | Protocol: Driver fusions, conventional RNA-seq of haematologic cell lines, validated truth (Tamura et al. 2026 Supplementary Table 5) Dataset: CCLE haematologic malignancy cell lines, conventional RNA-seq (170 cell lines) | 1 F1 (driver fusions, conventional RNA-seq of cell lines) fraction · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourceArriba on driver fusions, conventional RNA-seq (Tamura et al. 2026) rna-fusion-20261009-protocol-tamura2026-driver-conventional Aggregation: Not reported Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 5, 'Conventional RNA-seq of cell lines', row 'Arriba', column 'F1' (PDF page text) |
|---|
| Configuration: Arriba v2.1.0 (Tamura et al. 2026) | Protocol: Driver fusions, conventional RNA-seq of haematologic cell lines, validated truth (Tamura et al. 2026 Supplementary Table 5) Dataset: CCLE haematologic malignancy cell lines, conventional RNA-seq (170 cell lines) | 0 False negatives (driver fusions, conventional RNA-seq of cell lines) count · lower Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourceArriba on driver fusions, conventional RNA-seq (Tamura et al. 2026) rna-fusion-20261009-protocol-tamura2026-driver-conventional Aggregation: Not reported Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 5, 'Conventional RNA-seq of cell lines', row 'Arriba', column 'False negative' (PDF page text) |
|---|
| Configuration: Arriba v2.1.0 (Tamura et al. 2026) | Protocol: Driver fusions, conventional RNA-seq of haematologic cell lines, validated truth (Tamura et al. 2026 Supplementary Table 5) Dataset: CCLE haematologic malignancy cell lines, conventional RNA-seq (170 cell lines) | 0 False positives (driver fusions, conventional RNA-seq of cell lines) count · lower Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourceArriba on driver fusions, conventional RNA-seq (Tamura et al. 2026) rna-fusion-20261009-protocol-tamura2026-driver-conventional Aggregation: Not reported Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 5, 'Conventional RNA-seq of cell lines', row 'Arriba', column 'False positive' (PDF page text) |
|---|
| Configuration: Arriba v2.1.0 (Tamura et al. 2026) | Protocol: Driver fusions, conventional RNA-seq of haematologic cell lines, validated truth (Tamura et al. 2026 Supplementary Table 5) Dataset: CCLE haematologic malignancy cell lines, conventional RNA-seq (170 cell lines) | 1 Precision (driver fusions, conventional RNA-seq of cell lines) fraction · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourceArriba on driver fusions, conventional RNA-seq (Tamura et al. 2026) rna-fusion-20261009-protocol-tamura2026-driver-conventional Aggregation: Not reported Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 5, 'Conventional RNA-seq of cell lines', row 'Arriba', column 'Positive predictive value' (PDF page text) |
|---|
| Configuration: Arriba v2.1.0 (Tamura et al. 2026) | Protocol: Driver fusions, conventional RNA-seq of haematologic cell lines, validated truth (Tamura et al. 2026 Supplementary Table 5) Dataset: CCLE haematologic malignancy cell lines, conventional RNA-seq (170 cell lines) | 1 Recall (driver fusions, conventional RNA-seq of cell lines) fraction · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourceArriba on driver fusions, conventional RNA-seq (Tamura et al. 2026) rna-fusion-20261009-protocol-tamura2026-driver-conventional Aggregation: Not reported Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 5, 'Conventional RNA-seq of cell lines', row 'Arriba', column 'True positive rate' (PDF page text) |
|---|
| Configuration: Arriba v2.1.0 (Tamura et al. 2026) | Protocol: Driver fusions, conventional RNA-seq of haematologic cell lines, validated truth (Tamura et al. 2026 Supplementary Table 5) Dataset: CCLE haematologic malignancy cell lines, conventional RNA-seq (170 cell lines) | 61 True positives (driver fusions, conventional RNA-seq of cell lines) count · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourceArriba on driver fusions, conventional RNA-seq (Tamura et al. 2026) rna-fusion-20261009-protocol-tamura2026-driver-conventional Aggregation: Not reported Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 5, 'Conventional RNA-seq of cell lines', row 'Arriba', column 'True positive' (PDF page text) |
|---|
| Configuration: Arriba v2.1.0 (Tamura et al. 2026) | Protocol: Driver fusions, targeted RNA-seq of haematologic cell lines, validated truth (Tamura et al. 2026 Supplementary Table 5) Dataset: Haematologic cancer cell lines, hybridisation-capture targeted RNA-seq (26 cell lines) | 1 F1 (driver fusions, targeted RNA-seq of cell lines) fraction · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourceArriba on driver fusions, targeted RNA-seq (Tamura et al. 2026) rna-fusion-20261009-protocol-tamura2026-driver-targeted Aggregation: Not reported Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 5, 'Targeted RNA-seq of cell lines', row 'Arriba', column 'F1' (PDF page text) |
|---|
| Configuration: Arriba v2.1.0 (Tamura et al. 2026) | Protocol: Driver fusions, targeted RNA-seq of haematologic cell lines, validated truth (Tamura et al. 2026 Supplementary Table 5) Dataset: Haematologic cancer cell lines, hybridisation-capture targeted RNA-seq (26 cell lines) | 0 False negatives (driver fusions, targeted RNA-seq of cell lines) count · lower Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourceArriba on driver fusions, targeted RNA-seq (Tamura et al. 2026) rna-fusion-20261009-protocol-tamura2026-driver-targeted Aggregation: Not reported Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 5, 'Targeted RNA-seq of cell lines', row 'Arriba', column 'False negative' (PDF page text) |
|---|
| Configuration: Arriba v2.1.0 (Tamura et al. 2026) | Protocol: Driver fusions, targeted RNA-seq of haematologic cell lines, validated truth (Tamura et al. 2026 Supplementary Table 5) Dataset: Haematologic cancer cell lines, hybridisation-capture targeted RNA-seq (26 cell lines) | 0 False positives (driver fusions, targeted RNA-seq of cell lines) count · lower Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourceArriba on driver fusions, targeted RNA-seq (Tamura et al. 2026) rna-fusion-20261009-protocol-tamura2026-driver-targeted Aggregation: Not reported Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 5, 'Targeted RNA-seq of cell lines', row 'Arriba', column 'False positive' (PDF page text) |
|---|
| Configuration: Arriba v2.1.0 (Tamura et al. 2026) | Protocol: Driver fusions, targeted RNA-seq of haematologic cell lines, validated truth (Tamura et al. 2026 Supplementary Table 5) Dataset: Haematologic cancer cell lines, hybridisation-capture targeted RNA-seq (26 cell lines) | 1 Precision (driver fusions, targeted RNA-seq of cell lines) fraction · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourceArriba on driver fusions, targeted RNA-seq (Tamura et al. 2026) rna-fusion-20261009-protocol-tamura2026-driver-targeted Aggregation: Not reported Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 5, 'Targeted RNA-seq of cell lines', row 'Arriba', column 'Positive predictive value' (PDF page text) |
|---|
| Configuration: Arriba v2.1.0 (Tamura et al. 2026) | Protocol: Driver fusions, targeted RNA-seq of haematologic cell lines, validated truth (Tamura et al. 2026 Supplementary Table 5) Dataset: Haematologic cancer cell lines, hybridisation-capture targeted RNA-seq (26 cell lines) | 1 Recall (driver fusions, targeted RNA-seq of cell lines) fraction · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourceArriba on driver fusions, targeted RNA-seq (Tamura et al. 2026) rna-fusion-20261009-protocol-tamura2026-driver-targeted Aggregation: Not reported Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 5, 'Targeted RNA-seq of cell lines', row 'Arriba', column 'True positive rate' (PDF page text) |
|---|
| Configuration: Arriba v2.1.0 (Tamura et al. 2026) | Protocol: Driver fusions, targeted RNA-seq of haematologic cell lines, validated truth (Tamura et al. 2026 Supplementary Table 5) Dataset: Haematologic cancer cell lines, hybridisation-capture targeted RNA-seq (26 cell lines) | 24 True positives (driver fusions, targeted RNA-seq of cell lines) count · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourceArriba on driver fusions, targeted RNA-seq (Tamura et al. 2026) rna-fusion-20261009-protocol-tamura2026-driver-targeted Aggregation: Not reported Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 5, 'Targeted RNA-seq of cell lines', row 'Arriba', column 'True positive' (PDF page text) |
|---|